Lacroix-Desmazes, Sebastien and Wootla, Bharath and Dasgupta, Suryasarathi and Delignat, Sandrine and Bayry, Jagadeesh and Reinbolt, Joseph and Hoebeke, Johan and Saenko,, Evgueni and Kazatchkine, Michel D and Friboulet, Alain and Christophe,, Olivier and Valakunja, Nagaraja and Kaveri, Srini V (2006) Catalytic IgG from Patients with Hemophilia A Inactivate Therapeutic Factor VII. In: Journal Of Immunology, 177 (2). pp. 1355-1363.
1355.pdf - Published Version
Restricted to Registered users only
Download (220Kb) | Request a copy
Factor VIII (FVIII) inhibitors are anti-FVIII IgG that arise in up to 50% of the patients with hemophilia A, upon therapeutic administration of exogenous FVIII. Factor VIII inhibitors neutralize the activity of the administered FVIII by sterically hindering its interaction with molecules of the coagulation cascade, or by forming immune complexes with FVIII and accelerating its clearance from the circulation. We have shown previously that a subset of anti-factor VIII IgG hydrolyzes FVIII. FVIII-hydrolyzing IgG are detected in over 50% of inhibitor-positive patients with severe hemophilia A, and are not found in inhibitor-negative patients. Although human proficient catalytic Abs have been described in a number of inflammatory and autoimmune disorders, their pathological relevance remains elusive. We demonstrate here that the kinetics of FVIII degradation by FVIII-hydrolyzing IgG are compatible with a pathogenic role for IgG catalysts. We also report that FVIII-hydrolyzing IgG from each patient exhibit multiple cleavage sites on FVIII and that, while the specificity of cleavage varies from one patient to another, catalytic IgG preferentially hydrolyze peptide bonds containing basic amino acids.
|Item Type:||Journal Article|
|Additional Information:||Copypyright of this article belongs to The American Association for Immunologist|
|Department/Centre:||Division of Biological Sciences > Microbiology & Cell Biology|
|Date Deposited:||05 Mar 2009 12:48|
|Last Modified:||19 Sep 2010 05:24|
Actions (login required)